Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status

Glioblastomas epidemiology and aggressiveness demand for a well characterization of biochemical mechanisms of the cells. The discovery of oxidative tumours related to chemoresistance is changing the prevalent view of dysfunctional mitochondria in cancer cells. Thus, glioblastomas metabolism is now an area of intense research, wherein was documented a high heterogeneity in energy metabolism and in particular in mitochondrial OxPhos. We report results gained by investigating mitochondrial OxPhos and bioenergetics, in a model of three human glioblastoma cell lines characterized by a different PTEN gene status. Functional data are analysed in relation to the expression levels of some main transcription factors and signalling proteins, which can be involved in the regulation of mitochondrial biogenesis and activity. Collectively, our observations indicate for the three cell lines a similar bioenergetic phenotype maintaining a certain degree of mitochondrial oxidative activity, with some difference for PTEN-wild type SF767 cells respect to PTEN-deleted A172 and U87MG characterized by a loss-of-function point mutation of PTEN. SF767 has lower ATP content and higher ADP/ATP ratio, higher AMPK activating-phosphorylation evoking energy impairment, higher OxPhos complexes and PGC1α-Sirt3-p53 protein abundance, in line with a higher respiration. Finally, SF767 shows a similar mitochondrial energy supply, but higher non-phosphorylating respiration linked to dissipation of protonmotive force. Intriguingly, it is now widely accepted that a regulated mitochondrial proton leak attenuate ROS generation and in tumours may be at the base of pro-survival advantage and chemoresistance.

[1]  Roded Sharan,et al.  Genome-Scale Metabolic Modeling Elucidates the Role of Proliferative Adaptation in Causing the Warburg Effect , 2011, PLoS Comput. Biol..

[2]  A. Hoeflich,et al.  Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. , 2013, Mitochondrion.

[3]  Tunahan Çakır,et al.  Reconstructed Metabolic Network Models Predict Flux-Level Metabolic Reprogramming in Glioblastoma , 2016, Front. Neurosci..

[4]  Hong Wang,et al.  Mitochondrial Proton Leak Plays a Critical Role in Pathogenesis of Cardiovascular Diseases. , 2017, Advances in experimental medicine and biology.

[5]  Galina Polekhina,et al.  The identification of mitochondrial DNA variants in glioblastoma multiforme , 2014, Acta neuropathologica communications.

[6]  J. Liu,et al.  Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer , 2014, Cell Death and Disease.

[7]  Paola Pisani,et al.  Genetic Pathways to Glioblastoma , 2004, Cancer Research.

[8]  R. Scarpulla,et al.  Nuclear activators and coactivators in mammalian mitochondrial biogenesis. , 2002, Biochimica et biophysica acta.

[9]  I. Martínez-Reyes,et al.  Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells , 2013, EMBO reports.

[10]  N. Ahmad,et al.  Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential. , 2016, Cancer research.

[11]  E. White,et al.  Mitochondria and Cancer. , 2016, Molecular cell.

[12]  Oksana Gavrilova,et al.  p53 Regulates Mitochondrial Respiration , 2006, Science.

[13]  S. Baker,et al.  PTEN signaling in brain: neuropathology and tumorigenesis , 2008, Oncogene.

[14]  A. Di Cristofano,et al.  Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells. , 2013, Cancer research.

[15]  R. Parsons,et al.  The role of PTEN signaling perturbations in cancer and in targeted therapy , 2008, Oncogene.

[16]  Edilene S. Siqueira-Santos,et al.  Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity , 2017, Journal of Neuro-Oncology.

[17]  D. Turner,et al.  Exploiting metabolic differences in glioma therapy. , 2012, Current drug discovery technologies.

[18]  A. Chan,et al.  Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions , 2019, Cancers.

[19]  R. Deberardinis,et al.  Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. , 2012, Cell metabolism.

[20]  Pier Paolo Pandolfi,et al.  The Multiple Roles of PTEN in Tumor Suppression , 2000, Cell.

[21]  R. Moreno-Sánchez,et al.  Transcriptional Regulation of Energy Metabolism in Cancer Cells , 2019, Cells.

[22]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[23]  S. Weis,et al.  Alterations of oxidative phosphorylation complexes in astrocytomas , 2014, Glia.

[24]  M. Kaminishi,et al.  Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. , 2001, Biochemical and biophysical research communications.

[25]  Ivo Grosse,et al.  Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line , 2019, BMC Bioinformatics.

[26]  M. Fioramonti,et al.  AMPK in the central nervous system: physiological roles and pathological implications , 2016 .

[27]  Elena Bisetto,et al.  Cardiac differentiation promotes mitochondria development and ameliorates oxidative capacity in H9c2 cardiomyoblasts. , 2011, Mitochondrion.

[28]  N. Sundaresan,et al.  Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway* , 2009, The Journal of Biological Chemistry.

[29]  M. Brand,et al.  The on-off switches of the mitochondrial uncoupling proteins. , 2010, Trends in biochemical sciences.

[30]  F. Villarroya,et al.  SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. , 2012, The Biochemical journal.

[31]  J. Wands,et al.  The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. , 2008, Cancer research.

[32]  David Carling,et al.  Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .

[33]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[34]  D. Shackelford Unravelling the connection between metabolism and tumorigenesis through studies of the liver kinase B1 tumour suppressor , 2013, Journal of carcinogenesis.

[35]  Ming Liu,et al.  Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway. , 2016, Oncology Report.

[36]  M. Mintun,et al.  Nonoxidative glucose consumption during focal physiologic neural activity. , 1988, Science.

[37]  P. Kleihues,et al.  Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.

[38]  Miao Zhang,et al.  Activation of Protein Kinase Cζ by Peroxynitrite Regulates LKB1-dependent AMP-activated Protein Kinase in Cultured Endothelial Cells* , 2006, Journal of Biological Chemistry.

[39]  A. Ortega,et al.  The tumor suppressor function of mitochondria: translation into the clinics. , 2009, Biochimica et biophysica acta.

[40]  P. Verrelle,et al.  Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness , 2014, Journal of Neuro-Oncology.

[41]  D. Hardie AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. , 2011, Genes & development.

[42]  E. Gnaiger,et al.  High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. , 2012, Methods in molecular biology.

[43]  A. Echevarria,et al.  Sydnone SYD-1 affects the metabolic functions of isolated rat hepatocytes. , 2014, Chemico-biological interactions.

[44]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[45]  Pierre J Magistretti,et al.  Glutamate Transport Decreases Mitochondrial pH and Modulates Oxidative Metabolism in Astrocytes , 2011, The Journal of Neuroscience.

[46]  G. Tell,et al.  Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway. , 2019, DNA repair.

[47]  Marie Strickland,et al.  Metabolic Reprogramming in Glioma , 2017, Front. Cell Dev. Biol..

[48]  M. Poo,et al.  LKB1/STRAD Promotes Axon Initiation During Neuronal Polarization , 2007, Cell.

[49]  G. Kweon,et al.  High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma. , 2015, International journal of oncology.

[50]  T. Mesti,et al.  Malignant gliomas: old and new systemic treatment approaches , 2016, Radiology and oncology.

[51]  J. Bennett,et al.  Differentiation of Human Neural Stem Cells into Motor Neurons Stimulates Mitochondrial Biogenesis and Decreases Glycolytic Flux. , 2015, Stem cells and development.

[52]  H. Juan,et al.  Mitochondrial Lon regulates apoptosis through the association with Hsp60–mtHsp70 complex , 2015, Cell Death and Disease.

[53]  V. Tergaonkar,et al.  Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC , 2017, Front. Cell Dev. Biol..

[54]  M. Luo,et al.  Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway , 2016, Scientific Reports.

[55]  E. Gnaiger Polarographic Oxygen Sensors, the Oxygraph, and High‐Resolution Respirometry to Assess Mitochondrial Function , 2008 .

[56]  Rodrigue Rossignol,et al.  Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy. , 2015, The international journal of biochemistry & cell biology.

[57]  Fei Wang,et al.  Mitochondrial Uncoupling Inhibits p53 Mitochondrial Translocation in TPA-Challenged Skin Epidermal JB6 Cells , 2010, PloS one.

[58]  A. Merlo,et al.  Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines. , 1999, Brain pathology.

[59]  G. Yancey Gillespie,et al.  Glucose Metabolism Heterogeneity in Human and Mouse Malignant Glioma Cell Lines , 2005, Journal of Neuro-Oncology.

[60]  J. Lafuente,et al.  Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways , 2007, Journal of Molecular Neuroscience.

[61]  U. Moll,et al.  Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F₁F₀-ATP synthase , 2013, Cell cycle.

[62]  Li-Ming Zhou,et al.  Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation. , 2012, Biochemical and biophysical research communications.